EFFECT OF TRANEXAMIC ACID ON PRIMARY POSTPARTUM HAEMORRHAGE IN AT – RISK WOMEN AT ABUTH, ZARIA: A RANDOMIZED CONTROLLED STUDY

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202004568331645

Enrollment

334

Registered

2020-04-19

Start date

2019-07-30

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Haemorrhage

Interventions

Group A tranexamic acid group

Placebo Group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women with singleton pregnancy at gestational age: 37weeks 1day to 41weeks 6 days with any of the following risk factors: Previous history of PPH Nullipara Grand multipara Induced, augmented or prolonged labour Hypertensive disorders Obesity Anaemia (Hb<10g/dl) Bleeding disorders.

Exclusion criteria

Exclusion criteria: Non consenting women Diabetes mellitus in pregnancy Heart disease Renal disease Liver disease Past history of deep venous thrombosis Placenta praevia Severe abruption placentae Allergy to tranexamic acid

Design outcomes

Primary

Measure	Time frame
Proportion of women with blood loss > 500ml in both arms of the study	—

Secondary

Measure	Time frame
1. Percentage fall in haemoglobin 24 hours after delivery in both arms of the study. 2. Proportion of women in both arms who require additional uterotonics or manouvres. 3. Proportion of women in both arms who need blood transfusion 4. Any adverse effect of drug in the study group.	—

Countries

Nigeria

Contacts

Public ContactNana Hauwa Madugu

Consultant

madugu20007@yahoo.com+2348035896570

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026